0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Detection for Individualized Cancer Therapy Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-12P13441
Home | Market Reports | Health| Health Conditions| Cancer
Global Gene Detection for Individualized Cancer Therapy Market Research Report 2023
BUY CHAPTERS

Global Gene Detection for Individualized Cancer Therapy Market Research Report 2025

Code: QYRE-Auto-12P13441
Report
June 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gene Detection for Individualized Cancer Therapy Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Gene Detection for Individualized Cancer Therapy Market

Gene Detection for Individualized Cancer Therapy Market

The global market for Gene Detection for Individualized Cancer Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
A method to provide patients with individualized treatment of cancer tumors
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gene Detection for Individualized Cancer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Detection for Individualized Cancer Therapy.
The Gene Detection for Individualized Cancer Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Detection for Individualized Cancer Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Detection for Individualized Cancer Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Gene Detection for Individualized Cancer Therapy Market Report

Report Metric Details
Report Name Gene Detection for Individualized Cancer Therapy Market
CAGR 5%
Segment by Type
  • Genetic Screening
  • Reproductive Genetic Testing
  • Diagnostic Test
  • Gene carrier Test
  • Testing Before Symptoms Appear
Segment by Application
  • Hospital
  • Clinic
  • Diagnostic Center
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Premed, Yin Feng Gene, United Gene Group, Geneis, Topgen, Annoroad, Gene+, Sanvalley, Sansure
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Gene Detection for Individualized Cancer Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gene Detection for Individualized Cancer Therapy Market report?

Ans: The main players in the Gene Detection for Individualized Cancer Therapy Market are Premed, Yin Feng Gene, United Gene Group, Geneis, Topgen, Annoroad, Gene+, Sanvalley, Sansure

What are the Application segmentation covered in the Gene Detection for Individualized Cancer Therapy Market report?

Ans: The Applications covered in the Gene Detection for Individualized Cancer Therapy Market report are Hospital, Clinic, Diagnostic Center

What are the Type segmentation covered in the Gene Detection for Individualized Cancer Therapy Market report?

Ans: The Types covered in the Gene Detection for Individualized Cancer Therapy Market report are Genetic Screening, Reproductive Genetic Testing, Diagnostic Test, Gene carrier Test, Testing Before Symptoms Appear

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Genetic Screening
1.2.3 Reproductive Genetic Testing
1.2.4 Diagnostic Test
1.2.5 Gene carrier Test
1.2.6 Testing Before Symptoms Appear
1.3 Market by Application
1.3.1 Global Gene Detection for Individualized Cancer Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Diagnostic Center
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Detection for Individualized Cancer Therapy Market Perspective (2020-2031)
2.2 Global Gene Detection for Individualized Cancer Therapy Growth Trends by Region
2.2.1 Global Gene Detection for Individualized Cancer Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gene Detection for Individualized Cancer Therapy Historic Market Size by Region (2020-2025)
2.2.3 Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Region (2026-2031)
2.3 Gene Detection for Individualized Cancer Therapy Market Dynamics
2.3.1 Gene Detection for Individualized Cancer Therapy Industry Trends
2.3.2 Gene Detection for Individualized Cancer Therapy Market Drivers
2.3.3 Gene Detection for Individualized Cancer Therapy Market Challenges
2.3.4 Gene Detection for Individualized Cancer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Detection for Individualized Cancer Therapy Players by Revenue
3.1.1 Global Top Gene Detection for Individualized Cancer Therapy Players by Revenue (2020-2025)
3.1.2 Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Gene Detection for Individualized Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene Detection for Individualized Cancer Therapy Revenue
3.4 Global Gene Detection for Individualized Cancer Therapy Market Concentration Ratio
3.4.1 Global Gene Detection for Individualized Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Detection for Individualized Cancer Therapy Revenue in 2024
3.5 Global Key Players of Gene Detection for Individualized Cancer Therapy Head office and Area Served
3.6 Global Key Players of Gene Detection for Individualized Cancer Therapy, Product and Application
3.7 Global Key Players of Gene Detection for Individualized Cancer Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Detection for Individualized Cancer Therapy Breakdown Data by Type
4.1 Global Gene Detection for Individualized Cancer Therapy Historic Market Size by Type (2020-2025)
4.2 Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Type (2026-2031)
5 Gene Detection for Individualized Cancer Therapy Breakdown Data by Application
5.1 Global Gene Detection for Individualized Cancer Therapy Historic Market Size by Application (2020-2025)
5.2 Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gene Detection for Individualized Cancer Therapy Market Size (2020-2031)
6.2 North America Gene Detection for Individualized Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025)
6.4 North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Detection for Individualized Cancer Therapy Market Size (2020-2031)
7.2 Europe Gene Detection for Individualized Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025)
7.4 Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size (2020-2031)
8.2 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Detection for Individualized Cancer Therapy Market Size (2020-2031)
9.2 Latin America Gene Detection for Individualized Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025)
9.4 Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size (2020-2031)
10.2 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Premed
11.1.1 Premed Company Details
11.1.2 Premed Business Overview
11.1.3 Premed Gene Detection for Individualized Cancer Therapy Introduction
11.1.4 Premed Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.1.5 Premed Recent Development
11.2 Yin Feng Gene
11.2.1 Yin Feng Gene Company Details
11.2.2 Yin Feng Gene Business Overview
11.2.3 Yin Feng Gene Gene Detection for Individualized Cancer Therapy Introduction
11.2.4 Yin Feng Gene Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.2.5 Yin Feng Gene Recent Development
11.3 United Gene Group
11.3.1 United Gene Group Company Details
11.3.2 United Gene Group Business Overview
11.3.3 United Gene Group Gene Detection for Individualized Cancer Therapy Introduction
11.3.4 United Gene Group Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.3.5 United Gene Group Recent Development
11.4 Geneis
11.4.1 Geneis Company Details
11.4.2 Geneis Business Overview
11.4.3 Geneis Gene Detection for Individualized Cancer Therapy Introduction
11.4.4 Geneis Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.4.5 Geneis Recent Development
11.5 Topgen
11.5.1 Topgen Company Details
11.5.2 Topgen Business Overview
11.5.3 Topgen Gene Detection for Individualized Cancer Therapy Introduction
11.5.4 Topgen Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.5.5 Topgen Recent Development
11.6 Annoroad
11.6.1 Annoroad Company Details
11.6.2 Annoroad Business Overview
11.6.3 Annoroad Gene Detection for Individualized Cancer Therapy Introduction
11.6.4 Annoroad Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.6.5 Annoroad Recent Development
11.7 Gene+
11.7.1 Gene+ Company Details
11.7.2 Gene+ Business Overview
11.7.3 Gene+ Gene Detection for Individualized Cancer Therapy Introduction
11.7.4 Gene+ Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.7.5 Gene+ Recent Development
11.8 Sanvalley
11.8.1 Sanvalley Company Details
11.8.2 Sanvalley Business Overview
11.8.3 Sanvalley Gene Detection for Individualized Cancer Therapy Introduction
11.8.4 Sanvalley Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.8.5 Sanvalley Recent Development
11.9 Sansure
11.9.1 Sansure Company Details
11.9.2 Sansure Business Overview
11.9.3 Sansure Gene Detection for Individualized Cancer Therapy Introduction
11.9.4 Sansure Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
11.9.5 Sansure Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Genetic Screening
 Table 3. Key Players of Reproductive Genetic Testing
 Table 4. Key Players of Diagnostic Test
 Table 5. Key Players of Gene carrier Test
 Table 6. Key Players of Testing Before Symptoms Appear
 Table 7. Global Gene Detection for Individualized Cancer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Gene Detection for Individualized Cancer Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Gene Detection for Individualized Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Gene Detection for Individualized Cancer Therapy Market Share by Region (2020-2025)
 Table 11. Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Gene Detection for Individualized Cancer Therapy Market Share by Region (2026-2031)
 Table 13. Gene Detection for Individualized Cancer Therapy Market Trends
 Table 14. Gene Detection for Individualized Cancer Therapy Market Drivers
 Table 15. Gene Detection for Individualized Cancer Therapy Market Challenges
 Table 16. Gene Detection for Individualized Cancer Therapy Market Restraints
 Table 17. Global Gene Detection for Individualized Cancer Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Gene Detection for Individualized Cancer Therapy Market Share by Players (2020-2025)
 Table 19. Global Top Gene Detection for Individualized Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Detection for Individualized Cancer Therapy as of 2024)
 Table 20. Ranking of Global Top Gene Detection for Individualized Cancer Therapy Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Gene Detection for Individualized Cancer Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Gene Detection for Individualized Cancer Therapy, Headquarters and Area Served
 Table 23. Global Key Players of Gene Detection for Individualized Cancer Therapy, Product and Application
 Table 24. Global Key Players of Gene Detection for Individualized Cancer Therapy, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Gene Detection for Individualized Cancer Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Type (2020-2025)
 Table 28. Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Type (2026-2031)
 Table 30. Global Gene Detection for Individualized Cancer Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Application (2020-2025)
 Table 32. Global Gene Detection for Individualized Cancer Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Gene Detection for Individualized Cancer Therapy Revenue Market Share by Application (2026-2031)
 Table 34. North America Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Premed Company Details
 Table 50. Premed Business Overview
 Table 51. Premed Gene Detection for Individualized Cancer Therapy Product
 Table 52. Premed Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 53. Premed Recent Development
 Table 54. Yin Feng Gene Company Details
 Table 55. Yin Feng Gene Business Overview
 Table 56. Yin Feng Gene Gene Detection for Individualized Cancer Therapy Product
 Table 57. Yin Feng Gene Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 58. Yin Feng Gene Recent Development
 Table 59. United Gene Group Company Details
 Table 60. United Gene Group Business Overview
 Table 61. United Gene Group Gene Detection for Individualized Cancer Therapy Product
 Table 62. United Gene Group Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 63. United Gene Group Recent Development
 Table 64. Geneis Company Details
 Table 65. Geneis Business Overview
 Table 66. Geneis Gene Detection for Individualized Cancer Therapy Product
 Table 67. Geneis Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 68. Geneis Recent Development
 Table 69. Topgen Company Details
 Table 70. Topgen Business Overview
 Table 71. Topgen Gene Detection for Individualized Cancer Therapy Product
 Table 72. Topgen Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 73. Topgen Recent Development
 Table 74. Annoroad Company Details
 Table 75. Annoroad Business Overview
 Table 76. Annoroad Gene Detection for Individualized Cancer Therapy Product
 Table 77. Annoroad Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 78. Annoroad Recent Development
 Table 79. Gene+ Company Details
 Table 80. Gene+ Business Overview
 Table 81. Gene+ Gene Detection for Individualized Cancer Therapy Product
 Table 82. Gene+ Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 83. Gene+ Recent Development
 Table 84. Sanvalley Company Details
 Table 85. Sanvalley Business Overview
 Table 86. Sanvalley Gene Detection for Individualized Cancer Therapy Product
 Table 87. Sanvalley Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 88. Sanvalley Recent Development
 Table 89. Sansure Company Details
 Table 90. Sansure Business Overview
 Table 91. Sansure Gene Detection for Individualized Cancer Therapy Product
 Table 92. Sansure Revenue in Gene Detection for Individualized Cancer Therapy Business (2020-2025) & (US$ Million)
 Table 93. Sansure Recent Development
 Table 94. Research Programs/Design for This Report
 Table 95. Key Data Information from Secondary Sources
 Table 96. Key Data Information from Primary Sources
 Table 97. Authors List of This Report


List of Figures
 Figure 1. Gene Detection for Individualized Cancer Therapy Picture
 Figure 2. Global Gene Detection for Individualized Cancer Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gene Detection for Individualized Cancer Therapy Market Share by Type: 2024 VS 2031
 Figure 4. Genetic Screening Features
 Figure 5. Reproductive Genetic Testing Features
 Figure 6. Diagnostic Test Features
 Figure 7. Gene carrier Test Features
 Figure 8. Testing Before Symptoms Appear Features
 Figure 9. Global Gene Detection for Individualized Cancer Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Gene Detection for Individualized Cancer Therapy Market Share by Application: 2024 VS 2031
 Figure 11. Hospital Case Studies
 Figure 12. Clinic Case Studies
 Figure 13. Diagnostic Center Case Studies
 Figure 14. Gene Detection for Individualized Cancer Therapy Report Years Considered
 Figure 15. Global Gene Detection for Individualized Cancer Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Gene Detection for Individualized Cancer Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Gene Detection for Individualized Cancer Therapy Market Share by Region: 2024 VS 2031
 Figure 18. Global Gene Detection for Individualized Cancer Therapy Market Share by Players in 2024
 Figure 19. Global Top Gene Detection for Individualized Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Detection for Individualized Cancer Therapy as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Gene Detection for Individualized Cancer Therapy Revenue in 2024
 Figure 21. North America Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Gene Detection for Individualized Cancer Therapy Market Share by Country (2020-2031)
 Figure 23. United States Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Gene Detection for Individualized Cancer Therapy Market Share by Country (2020-2031)
 Figure 27. Germany Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Gene Detection for Individualized Cancer Therapy Market Share by Region (2020-2031)
 Figure 35. China Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Gene Detection for Individualized Cancer Therapy Market Share by Country (2020-2031)
 Figure 43. Mexico Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Gene Detection for Individualized Cancer Therapy Market Share by Country (2020-2031)
 Figure 47. Turkey Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Gene Detection for Individualized Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Premed Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
 Figure 51. Yin Feng Gene Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
 Figure 52. United Gene Group Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
 Figure 53. Geneis Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
 Figure 54. Topgen Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
 Figure 55. Annoroad Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
 Figure 56. Gene+ Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
 Figure 57. Sanvalley Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
 Figure 58. Sansure Revenue Growth Rate in Gene Detection for Individualized Cancer Therapy Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart